GAL and diabetes mellitus: The roles played by GAL-like peptide and GAL 2 receptor agonists as antidiabetic agents for the treatment of diabetes (type 2)/insulin resistance must be investigated and confirmed, and the role played by the neurosecretory protein GL in feeding behaviour must be fully elucidated.